GI & Endoscopy

Here are seven must-reads on the treatment of hepatitis C.

Express Scripts, one of the largest pharmacy benefit managers in the country, will cover AbbVie's new hepatitis C treatment and will no longer cover Gilead Sciences treatments, according to a Reuters report.

In December 2014 the a American Society of Gastrointestinal Endoscopy and American College of Gastroenterology joint task force released updated quality indictors that span a broad range of GI/endoscopy procedures.

What New Year’s resolutions are gastroenterologists making for 2015?

Here are the 10 most-read gastroenterology and endoscopy stories on Becker's ASC Review in 2014.

Actavis appointed Jonathon Kellerman as executive vice president, global chief compliance officer. 

A new study, published in Colorectal Disease, examines histopathology changes after non-ablative radiofrequency to smooth muscle as delivered by Stretta therapy for gastroesophageal reflux disease and Secca therapy for fecal incontinence.

The American Gastroenterological Association Center for GI Innovation and Technology's STAR Registry has enrolled its first two patients.  

Medicare often set trends for commercial payers, and Highmark has determined it will opt for Medicare's stance and lift restrictions on colorectal cancer screening drugs, according to a Pittsburgh Business Times report.

TiGenix submitted the required documentation for a Special Protocol Assessment of its pivotal Phase III trial design for Cx601 to the U.S. Food and Drug Administration.